Olubukola T Idoko

Summary

Affiliation: Medical Research Council Laboratories
Country: The Gambia

Publications

  1. ncbi request reprint Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial
    Olubukola T Idoko
    Medical Research Council Unit, The Gambia, PO Box 273, Banjul, Gambia Electronic address
    Tuberculosis (Edinb) 94:564-78. 2014
  2. ncbi request reprint Lessons in participant retention in the course of a randomized controlled clinical trial
    Olubukola T Idoko
    Medical Research Council Unit, P, O Box 273, Banjul, The Gambia
    BMC Res Notes 7:706. 2014
  3. ncbi request reprint Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups
    O T Idoko
    Medical Research Council Unit, The Gambia Electronic address
    Vaccine 32:4620-4. 2014
  4. ncbi request reprint The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines
    Olubukola T Idoko
    Medical Research Council Unit, P O Box 273, The Gambia Electronic address
    Vaccine 32:4220-7. 2014
  5. pmc Impact, challenges, and future projections of vaccine trials in Africa
    Olubukola T Idoko
    Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia
    Am J Trop Med Hyg 88:414-9. 2013

Detail Information

Publications5

  1. ncbi request reprint Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial
    Olubukola T Idoko
    Medical Research Council Unit, The Gambia, PO Box 273, Banjul, Gambia Electronic address
    Tuberculosis (Edinb) 94:564-78. 2014
    ..We evaluated the candidate tuberculosis vaccine M72/AS01 in Bacille-Calmette-Guérin (BCG)-vaccinated infants after or concomitantly with Expanded-Programme-on-Immunization (EPI) vaccines...
  2. ncbi request reprint Lessons in participant retention in the course of a randomized controlled clinical trial
    Olubukola T Idoko
    Medical Research Council Unit, P, O Box 273, Banjul, The Gambia
    BMC Res Notes 7:706. 2014
    ..This article shares experiences from a phase II trial that recorded a high retention rate at 14 months follow-up at a new clinical trial site...
  3. ncbi request reprint Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups
    O T Idoko
    Medical Research Council Unit, The Gambia Electronic address
    Vaccine 32:4620-4. 2014
    ..This suggests a population with insufficient or waning antibody that may be susceptible to breakthrough disease and transmission...
  4. ncbi request reprint The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines
    Olubukola T Idoko
    Medical Research Council Unit, P O Box 273, The Gambia Electronic address
    Vaccine 32:4220-7. 2014
    ..This finding may have some implications for vaccination strategies adopted in the future. ..
  5. pmc Impact, challenges, and future projections of vaccine trials in Africa
    Olubukola T Idoko
    Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia
    Am J Trop Med Hyg 88:414-9. 2013
    ..This review seeks to highlight the issues surrounding the conduct of clinical trials in resource-constrained settings and suggests some ways of circumventing them...